Author(s)

Roland Bertile Banga-Mouss¹, Yanick Dimi Nyanga¹, Brice Nkoua Epala², Armel Melvin Atipo Ondongo¹, Steve Aristid Ondziel-Opara¹, Eliane Ndounga², Alexis Bolenga², Louis Constant Mbele Mantsouaka², Judith Nsonde Malanda², Aanani Séverin Wencesl Odzébé^1*, Prosper Alain Bouya¹

¹Departement of Urology and Andrology, University Hospital of Brazzaville, Brazzaville, Republic of the Congo.
²Departement of Medicale Oncology and Radiotherapy, University Hospital of Brazzaville, Brazzaville, Republic of the Congo.

Introduction: Testicular cancer accounts for 5% of urological tumors, predominantly affecting young men. The aim of our study was to report the diagnostic and evolutionary aspects of testicular cancer cases treated in our center. Patients and Methods: A retrospective study conducted over a 15-year period involving 12 patients treated for testicular cancer at the University Hospital of Brazzaville. Results: The median age was 31 years (range 11 to 49 years), with a median consultation delay of 10.6 months (range 3 to 27 months). Scrotal mass was the most common reason for consultation. Cancer was bilateral in two patients. Two patients were admitted with metastatic disease. Histopathological examination favored germ cell tumors in 7 cases, two cases of non-Hodgkin’s malignant lymphoma, and one case of epididymo-testicular adenocarcinoma. Adjuvant chemotherapy resulted in complete remission in patients with germ cell tumors. However, neoadjuvant chemotherapy was not effective in patients admitted with advanced-stage disease. Conclusion: Testicular cancer is a rare condition that is curable in the majority of cases, but its management is often complicated in our setting due to delayed diagnosis caused by taboos surrounding genital organ pathologies.

Testicular Cancer, Germ Cell Tumor, Cisplatin, Testicular Lymphoma, Testicular Adenocarcinoma

Banga-Mouss, R. , Nyanga, Y. , Epala, B. , Ondongo, A. , Ondziel-Opara, S. , Ndounga, E. , Bolenga, A. , Mantsouaka, L. , Malanda, J. , Odzébé, A. and Bouya, P. (2024) Management of Testicular Cancers in Brazzaville. Open Journal of Urology, 14, 324-332. doi: 10.4236/oju.2024.145034.